{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:38:03Z","timestamp":1792643883148,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the ITC grants","award":["MHP\/004\/19 and ITCPD\/17-9"],"award-info":[{"award-number":["MHP\/004\/19 and ITCPD\/17-9"]}]},{"name":"the ITC grants","award":["MHP\/004\/19 and ITCPD\/17-9"],"award-info":[{"award-number":["MHP\/004\/19 and ITCPD\/17-9"]}]},{"name":"NSFC\/RGC Collaborative Research Scheme","award":["no. CRS_HKUST605\/22"],"award-info":[{"award-number":["no. CRS_HKUST605\/22"]}]},{"name":"NSFC\/RGC Collaborative Research Scheme","award":["no. CRS_HKUST605\/22"],"award-info":[{"award-number":["no. CRS_HKUST605\/22"]}]},{"name":"CAS-Croucher Funding Scheme for Joint Laboratories","award":["CAS24SC03"],"award-info":[{"award-number":["CAS24SC03"]}]},{"name":"CAS-Croucher Funding Scheme for Joint Laboratories","award":["CAS24SC03"],"award-info":[{"award-number":["CAS24SC03"]}]},{"name":"the RGC grants","award":["R6003\u201322, C6034-21G, C6040-24G, 16101021, 16102724, T12-705-24-R"],"award-info":[{"award-number":["R6003\u201322, C6034-21G, C6040-24G, 16101021, 16102724, T12-705-24-R"]}]},{"name":"the RGC grants","award":["R6003\u201322, C6034-21G, C6040-24G, 16101021, 16102724, T12-705-24-R"],"award-info":[{"award-number":["R6003\u201322, C6034-21G, C6040-24G, 16101021, 16102724, T12-705-24-R"]}]},{"name":"National Key Research and Development Program of China","award":["2025YFF1207901"],"award-info":[{"award-number":["2025YFF1207901"]}]},{"name":"National Key Research and Development Program of China","award":["2025YFF1207901"],"award-info":[{"award-number":["2025YFF1207901"]}]},{"name":"Beijing Natural Science Foundation","award":["Z220012"],"award-info":[{"award-number":["Z220012"]}]},{"name":"Beijing Natural Science Foundation","award":["Z220012"],"award-info":[{"award-number":["Z220012"]}]},{"name":"Padma Harilela Professorship and Sinovac fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16597-9","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:32:49Z","timestamp":1784874769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RBFOX3 is associated with neuronal-like phenotypic transition in recurrent glioblastoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaomeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichao","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"8","key":"16597_CR1","first-page":"1231","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neurooncology. 2021;23(8):1231\u201351.","journal-title":"Neurooncology"},{"issue":"17","key":"16597_CR2","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842\u201350.","journal-title":"JAMA"},{"issue":"10","key":"16597_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"1","key":"16597_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-023-01165-8","volume":"15","author":"Y Nam","year":"2023","unstructured":"Nam Y, et al. Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma. Genome Med. 2023;15(1):1\u201315.","journal-title":"Genome Med"},{"issue":"7","key":"16597_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.3590","volume":"48","author":"J Wang","year":"2016","unstructured":"Wang J, et al. Clonal evolution of glioblastoma under therapy. Nat Genet. 2016;48(7):768\u201376.","journal-title":"Nat Genet"},{"issue":"716","key":"16597_CR6","doi-asserted-by":"publisher","first-page":"eadh4181","DOI":"10.1126\/scitranslmed.adh4181","volume":"15","author":"Q Mu","year":"2023","unstructured":"Mu Q, et al. Identifying predictors of glioma evolution from longitudinal sequencing. Sci Transl Med. 2023;15(716):eadh4181.","journal-title":"Sci Transl Med"},{"issue":"12","key":"16597_CR7","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang L, et al. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets. Nat cancer. 2022;3(12):1534\u201352.","journal-title":"Nat cancer"},{"issue":"3","key":"16597_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ccell.2023.12.015","volume":"42","author":"K-H Kim","year":"2024","unstructured":"Kim K-H, et al. Integrated proteogenomic characterization of glioblastoma evolution. Cancer Cell. 2024;42(3):358\u201377. e8.","journal-title":"Cancer Cell"},{"key":"16597_CR9","unstructured":"Spitzer A et al. Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics. Nat Genet, 2025: pp. 1\u201311."},{"issue":"4","key":"16597_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","volume":"41","author":"Y Hoogstrate","year":"2023","unstructured":"Hoogstrate Y, et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell. 2023;41(4):678\u201392. e7.","journal-title":"Cancer Cell"},{"issue":"6","key":"16597_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ccell.2021.05.002","volume":"39","author":"T Hara","year":"2021","unstructured":"Hara T, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell. 2021;39(6):779\u201392. e11.","journal-title":"Cancer Cell"},{"issue":"12","key":"16597_CR12","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.cell.2022.04.038","volume":"185","author":"FS Varn","year":"2022","unstructured":"Varn FS, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. 2022;185(12):2184\u201399. e16.","journal-title":"Cell"},{"issue":"19","key":"16597_CR13","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen A, et al. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. 2016;35(19):2413\u201327.","journal-title":"Oncogene"},{"issue":"7377","key":"16597_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature10662","volume":"480","author":"PI Poulikakos","year":"2011","unstructured":"Poulikakos PI, et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E). Nature. 2011;480(7377):387\u201390.","journal-title":"Nature"},{"issue":"45","key":"16597_CR15","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.1038\/s41388-020-01479-6","volume":"39","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, et al. Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors. Oncogene. 2020;39(45):6935\u201349.","journal-title":"Oncogene"},{"issue":"1","key":"16597_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-021-02259-5","volume":"22","author":"L Wang","year":"2021","unstructured":"Wang L, et al. The evolution of alternative splicing in glioblastoma under therapy. Genome Biol. 2021;22(1):1\u201315.","journal-title":"Genome Biol"},{"issue":"1","key":"16597_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"51","key":"16597_CR18","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci. 2014;111(51):E5593\u2013601.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"16597_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98\u2013110.","journal-title":"Cancer Cell"},{"key":"16597_CR20","doi-asserted-by":"crossref","unstructured":"Wu T et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov, 2021. 2(3).","DOI":"10.1016\/j.xinn.2021.100141"},{"issue":"2","key":"16597_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"16597_CR22","unstructured":"Haas T. inferCNV of the Trinity CTAT Project. 2019."},{"issue":"4","key":"16597_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C, et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell. 2019;178(4):835\u201349. e21.","journal-title":"Cell"},{"issue":"1","key":"16597_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics. Nat Protoc. 2025;20(1):180\u2013219.","journal-title":"Nat Protoc"},{"issue":"6","key":"16597_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","volume":"40","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell. 2022;40(6):639\u201355. e13.","journal-title":"Cancer Cell"},{"issue":"4","key":"16597_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable DM, et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol. 2022;40(4):517\u201326.","journal-title":"Nat Biotechnol"},{"issue":"21","key":"16597_CR27","doi-asserted-by":"publisher","first-page":"2414493","DOI":"10.1002\/advs.202414493","volume":"12","author":"L Zhou","year":"2025","unstructured":"Zhou L, et al. MRAS: master regulator analysis of alternative splicing. Adv Sci. 2025;12(21):2414493.","journal-title":"Adv Sci"},{"issue":"6","key":"16597_CR28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gr.199935.115","volume":"26","author":"E Sebesty\u00e9n","year":"2016","unstructured":"Sebesty\u00e9n E, et al. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res. 2016;26(6):732\u201344.","journal-title":"Genome Res"},{"issue":"2","key":"16597_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/cancers10020042","volume":"10","author":"J-F Groulx","year":"2018","unstructured":"Groulx J-F, Boudjadi S, Beaulieu J-F. MYC regulates \u03b16 integrin subunit expression and splicing under its pro-proliferative ITGA6A form in colorectal cancer cells. Cancers. 2018;10(2):42.","journal-title":"Cancers"},{"issue":"6","key":"16597_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/carcin\/bgu006","volume":"35","author":"J-F Groulx","year":"2014","unstructured":"Groulx J-F, et al. Integrin \u03b16A splice variant regulates proliferation and the Wnt\/\u03b2-catenin pathway in human colorectal cancer cells. Carcinogenesis. 2014;35(6):1217\u201327.","journal-title":"Carcinogenesis"},{"issue":"11","key":"16597_CR31","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1242\/jcs.108.11.3419","volume":"108","author":"MI Reinhold","year":"1995","unstructured":"Reinhold MI, et al. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci. 1995;108(11):3419\u201325.","journal-title":"J Cell Sci"},{"key":"16597_CR32","doi-asserted-by":"publisher","first-page":"1329562","DOI":"10.3389\/fimmu.2024.1329562","volume":"15","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wang F, Yang Y-G. Structural\u2013functional diversity of CD47 proteoforms. Front Immunol. 2024;15:1329562.","journal-title":"Front Immunol"},{"issue":"3","key":"16597_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1046\/j.1471-4159.1996.66031273.x","volume":"66","author":"WJ Chung","year":"1996","unstructured":"Chung WJ, et al. MAP2a, an alternatively spliced variant of microtubule-associated protein 2. J Neurochem. 1996;66(3):1273\u201381.","journal-title":"J Neurochem"},{"issue":"1","key":"16597_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/gb-2004-6-1-204","volume":"6","author":"L Dehmelt","year":"2004","unstructured":"Dehmelt L, Halpain S. The MAP2\/Tau family of microtubule-associated proteins. Genome Biol. 2004;6(1):204.","journal-title":"Genome Biol"},{"issue":"5573","key":"16597_CR35","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655\u20137.","journal-title":"Science"},{"issue":"23","key":"16597_CR36","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.94.23.12479","volume":"94","author":"FB Furnari","year":"1997","unstructured":"Furnari FB, et al. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci. 1997;94(23):12479\u201384.","journal-title":"Proc Natl Acad Sci"},{"issue":"7576","key":"16597_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang L, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100\u20134.","journal-title":"Nature"},{"issue":"1","key":"16597_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1874467211205010102","volume":"5","author":"J Zhang","year":"2012","unstructured":"Zhang J, Stevens MFG, Bradshaw TD. Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol. 2012;5(1):102\u201314.","journal-title":"Curr Mol Pharmacol"},{"issue":"4","key":"16597_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12094-017-1743-x","volume":"20","author":"J Stritzelberger","year":"2018","unstructured":"Stritzelberger J, et al. Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine. Clin Transl Oncol. 2018;20(4):508\u201316.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"16597_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13073-023-01165-8","volume":"15","author":"Y Nam","year":"2023","unstructured":"Nam Y, et al. Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma. Genome Med. 2023;15(1):16.","journal-title":"Genome Med"},{"issue":"10","key":"16597_CR41","first-page":"1693","volume":"23","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Spliceosome-regulated RSRP1-dependent NF-\u03baB activation promotes the glioblastoma mesenchymal phenotype. Neurooncology. 2021;23(10):1693\u2013708.","journal-title":"Neurooncology"},{"key":"16597_CR42","doi-asserted-by":"crossref","unstructured":"Tsang SM, Oliemuller E. Howard. Regulatory roles for SOX11 in development, stem cells and cancer. Seminars in cancer biology. Elsevier; 2020.","DOI":"10.1016\/j.semcancer.2020.06.015"},{"issue":"7775","key":"16597_CR43","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani V, et al. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature. 2019;573(7775):532\u20138.","journal-title":"Nature"},{"issue":"7775","key":"16597_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh HS, et al. Electrical and synaptic integration of glioma into neural circuits. Nature. 2019;573(7775):539\u201345.","journal-title":"Nature"},{"issue":"7986","key":"16597_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-023-06678-1","volume":"623","author":"KR Taylor","year":"2023","unstructured":"Taylor KR, et al. Glioma synapses recruit mechanisms of adaptive plasticity. Nature. 2023;623(7986):366\u201374.","journal-title":"Nature"},{"issue":"10","key":"16597_CR46","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald AC, et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell. 2024;187(10):2485\u2013501. e26.","journal-title":"Cell"},{"key":"16597_CR47","unstructured":"Shah N et al. A spatially resolved human glioblastoma atlas reveals distinct cellular and molecular patterns of anatomical niches. 2024."},{"issue":"5","key":"16597_CR48","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1261\/rna.876308","volume":"14","author":"Z Wang","year":"2008","unstructured":"Wang Z, Burge CB. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA. 2008;14(5):802\u201313.","journal-title":"RNA"},{"issue":"1","key":"16597_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41392-021-00495-6","volume":"6","author":"Y Lv","year":"2021","unstructured":"Lv Y, et al. SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Signal Transduct Target Therapy. 2021;6(1):108.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"16597_CR50","doi-asserted-by":"publisher","first-page":"7732","DOI":"10.1038\/s41467-023-43605-4","volume":"14","author":"ND Moss","year":"2023","unstructured":"Moss ND, et al. Modulation of insulin secretion by RBFOX2-mediated alternative splicing. Nat Commun. 2023;14(1):7732.","journal-title":"Nat Commun"},{"issue":"2","key":"16597_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s43018-020-00159-4","volume":"2","author":"L Garofano","year":"2021","unstructured":"Garofano L, et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities. Nat Cancer. 2021;2(2):141\u201356.","journal-title":"Nat Cancer"},{"issue":"5","key":"16597_CR52","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.cell.2016.07.025","volume":"166","author":"X Zhang","year":"2016","unstructured":"Zhang X, et al. Cell-type-specific alternative splicing governs cell fate in the developing cerebral cortex. Cell. 2016;166(5):1147\u201362. e15.","journal-title":"Cell"},{"issue":"4","key":"16597_CR53","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.neuron.2018.01.020","volume":"97","author":"M Jacko","year":"2018","unstructured":"Jacko M, et al. Rbfox splicing factors promote neuronal maturation and axon initial segment assembly. Neuron. 2018;97(4):853\u201368. e6.","journal-title":"Neuron"},{"issue":"8Part1","key":"16597_CR54","first-page":"1315","volume":"23","author":"G Warwick","year":"1963","unstructured":"Warwick G. The mechanism of action of alkylating agents. Cancer Res. 1963;23(8Part1):1315\u201333.","journal-title":"Cancer Res"},{"issue":"2","key":"16597_CR55","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti R, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009;138(2):286\u201399.","journal-title":"Cell"},{"issue":"1","key":"16597_CR56","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41467-020-15129-8","volume":"11","author":"CA von Roemeling","year":"2020","unstructured":"von Roemeling CA, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11(1):1508.","journal-title":"Nat Commun"},{"issue":"48","key":"16597_CR57","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1523\/JNEUROSCI.3981-06.2006","volume":"26","author":"T Murata","year":"2006","unstructured":"Murata T, et al. CD47 promotes neuronal development through Src-and FRG\/Vav2-mediated activation of Rac and Cdc42. J Neurosci. 2006;26(48):12397\u2013407.","journal-title":"J Neurosci"},{"issue":"3","key":"16597_CR58","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.celrep.2014.03.059","volume":"7","author":"HL Goel","year":"2014","unstructured":"Goel HL, et al. Regulated splicing of the \u03b16 integrin cytoplasmic domain determines the fate of breast cancer stem cells. Cell Rep. 2014;7(3):747\u201361.","journal-title":"Cell Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16597-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16597-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16597-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:48:36Z","timestamp":1792640916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16597-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16597"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16597-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1271"}}